0001964306-24-000015.txt : 20240119 0001964306-24-000015.hdr.sgml : 20240119 20240119163519 ACCESSION NUMBER: 0001964306-24-000015 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240119 DATE AS OF CHANGE: 20240119 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Acumen Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001576885 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 364108129 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-40551 FILM NUMBER: 24546068 BUSINESS ADDRESS: STREET 1: 427 PARK ST. CITY: CHARLOTTESVILLE STATE: VA ZIP: 22902 BUSINESS PHONE: 925-368-8508 MAIL ADDRESS: STREET 1: 427 PARK ST. CITY: CHARLOTTESVILLE STATE: VA ZIP: 22902 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: OConnell Daniel Joseph CENTRAL INDEX KEY: 0001865136 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O ACUMEN PHARMACEUTICALS, INC. STREET 2: 427 PARK STREET CITY: CHARLOTTESVILLE STATE: VA ZIP: 22902 144 1 primary_doc.xml 144 0001865136 XXXXXXXX LIVE 0001576885 Acumen Pharmaceuticals, Inc. 001-40551 427 PARK ST. CHARLOTTESVILLE VA 22902 925-368-8508 OConnell Daniel Joseph Officer Director Common Stock Merrill Lynch

225 Liberty Street Floor 37 New York NY 10281

15200 52752.59 57910461 01/19/2024 NASDAQ Common Stock 01/17/2024 Vesting of restricted stock unit award Acumen Pharmaceuticals, Inc. N 15200 01/17/2024 Granted as part of issuer equity compensation plan Y 01/19/2024 06/09/2023 Daniel O'Connell